Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sulfhydryl-containing cellular enzymes are a diverse group of proteins characterized by the presence of cysteine-derived sulfhydryl (-SH) groups. These moieties are central to enzymatic activity, regulation, and structural integrity, mainly through their role in redox reactions and disulfide bond formation. Enzymes such as proteases, oxidoreductases, transferases, and deubiquitinases utilize sulfhydryl groups for catalytic mechanisms or as redox sensors. Post-translational modifications of enzyme cysteines expand functional diversity and are implicated in regulation, signaling, and disease pathogenesis. Therapeutically, many drugs interact with, or target, sulfhydryl groups to modulate enzyme function or cellular redox states; however, the broad distribution of these groups across the proteome necessitates careful drug design to avoid off-target toxicity.
Covalent modification of cysteine sulfhydryl groups; Redox modulation through oxidation or reduction; Enzyme inhibition by targeting active-site thiols; Activation of cytoprotective pathways (KEAP1/NRF2)
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sulfhydryl-containing cellular enzyme.